Basic Information
Ollin Biosciences™, founded in 2023, is a clinical-stage biopharmaceutical company dedicated to acquiring and developing the best disease therapies for vision-threatening conditions. With a differentiated pipeline, a world-class team, and a strong consortium of investors, Ollin is redefining the possibilities in ophthalmology.
Ollin Biosciences, Inc.
Austin,Texas,United States of America
15~50 people
January 01, 2023
katie@1abmedia.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios